Sat Kartar Life Limited (NSE:SATKARTAR)
India · Delayed Price · Currency is INR 187.70
+8.25 (4.60%)
At close: Sep 25, 2026
Sat Kartar Life Revenue
In the fiscal year ending March 31, 2026, Sat Kartar Life had annual revenue of 2.01B INR with 23.19% growth. Sat Kartar Life had revenue of 543.78M in the quarter ending March 31, 2026, with 1.38% growth.
Revenue
2.01B
Revenue Growth
+23.19%
P/S Ratio
1.47
Revenue / Employee
n/a
Employees
922
Market Cap
2.96B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.01B | 377.74M | 23.19% |
| Mar 31, 2025 | 1.63B | 350.12M | 27.37% |
| Mar 31, 2024 | 1.28B | 449.40M | 54.16% |
| Mar 31, 2023 | 829.70M | 306.62M | 58.62% |
| Mar 31, 2022 | 523.07M | 233.69M | 80.75% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.73B |
| Medico Remedies | 2.38B |
| Ambalal Sarabhai Enterprises | 2.06B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Jenburkt Pharmaceuticals | 1.69B |
| Astonea Labs | 1.48B |
| BDH Industries | 997.10M |